4552.T

JCR Pharmaceuticals Co., Ltd. [4552.T] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

4552.T Stock Summary

Top 4552.T Correlated Resources

4552.T

Top 10 Correlated ETFs

4552.T

Top 10 Correlated Stocks

4552.T

In the News

4552.T Financial details

Company Rating
-
Market Cap
104.21B
Income
5.37B
Revenue
41.37B
Book val./share
-
Cash/share
-
Dividend
20
Dividend %
1.67%
Employees
879
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
18.59
Forward P/E
-
PEG
-2.93
P/S
3.47
P/B
2.64
P/C
-
P/FCF
-
Quick Ratio
1.14
Current Ratio
1.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
42.98
EPS next Y
-
EPS next Q
-
EPS this Y
-74.13%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.11%
Revenue last 5Y
8.2%
Revenue Q/Q
-29.84%
EPS Q/Q
-102.54%
-
-
-
-
SMA20
-7.54%
SMA50
-10.44%
SMA100
-35%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
15%
ROC
0.15%
Gross Margin
77%
Oper. Margin
26%
Profit Margin
19%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
788.0-1567.0
52W High
-68.47%
52W Low
-37.31%
RSI
57.66
Rel Volume
0.26
Avg Volume
724.38K
Volume
191.4K
Perf Week
10.02%
Perf Month
-5.9%
Perf Quarter
-28.3%
Perf Half Y
-24.7%
-
-
-
-
Beta
-0.006
-
-
Volatility
15.37%, 42.62%
Prev Close
-0.2%
Price
494
Change
0.82%

4552.T Financial Performance

4552.T Dividend History

4552.T Frequently Asked Questions

What is JCR Pharmaceuticals Co., Ltd. stock symbol ?

JCR Pharmaceuticals Co., Ltd. is a JP stock and trading under the symbol 4552.T

What is JCR Pharmaceuticals Co., Ltd. stock quote today ?

JCR Pharmaceuticals Co., Ltd. stock price is $494 today.

Is JCR Pharmaceuticals Co., Ltd. stock public?

Yes, JCR Pharmaceuticals Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
NVD.DE
M&M.NS
AAPL
0YXG.L
AVGO
Top Correlated ETFs
XBM.TO
DBJP
DXJ
HEWJ
COPX
Top Correlated Stocks
1963.T
2120.T
4043.T
4082.T
4092.T
Similar Market Cap
0J8W.L
1926.T
1997.HK
003816.SZ
AIR.PA

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 724.38K
  • Market Capitalization 104.21B
  • Employee 879
  • CEO Mr. Shin Ashida
  • Headquarters Ashiya,JP
  • IPO Date 2005-11-17
  • Website https://www.jcrpharm.co.jp

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.